Whitehawk Therapeutics, Inc. — Director's Dealing 2021

Aug 31, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aadi Bioscience, Inc. (AADI)
CIK: 0001422142
Period of Report: 2021-08-26

Reporting Person: Maroun Richard E (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.20	2027-08-08	Common Stock (15860)		Direct
Stock Option (right to buy)	$8.60	2031-06-23	Common Stock (7930)		Direct

Footnotes

F1: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Aadi Subsidiary, Inc. Amended and Restated 2014 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and, thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 28, 2017.

F2: The shares subject to the option became fully vested and exercisable on August 26, 2021.